z-logo
open-access-imgOpen Access
Updated peer review of the pesticide risk assessment of the active substance bifenazate
Author(s) -
Alvarez Fernando,
Arena Maria,
Auteri Domenica,
Borroto Jorge,
Brancato Alba,
Carrasco Cabrera Luis,
Castoldi Anna Federica,
Chiusolo Arianna,
Colagiorgi Angelo,
Colas Mathilde,
Crivellente Federica,
De Lentdecker Chloe,
Egsmose Mark,
Fait Gabriella,
Gouliarmou Varvara,
Ferilli Franco,
Greco Luna,
Ippolito Alessio,
Istace Frederique,
Jarrah Samira,
Kardassi Dimitra,
Kienzler Aude,
Leuschner Renata,
Lava Roberto,
Linguadoca Alberto,
Lythgo Christopher,
Magrans Oriol,
Mangas Iris,
Miron Ileana,
Molnar Tunde,
Padovani Laura,
Parra Morte Juan Manuel,
Pedersen Ragnor,
Reich Hermine,
Santos Miguel,
Sharp Rachel,
Szentes Csaba,
Terron Andrea,
Tiramani Manuela,
Vagenende Benedicte,
VillamarBouza Laura
Publication year - 2021
Publication title -
efsa journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.076
H-Index - 97
ISSN - 1831-4732
DOI - 10.2903/j.efsa.2021.6818
Subject(s) - context (archaeology) , acaricide , european commission , risk assessment , member states , pesticide , environmental health , european union , toxicology , business , medicine , biology , computer security , agronomy , computer science , paleontology , economic policy
The conclusions of the EFSA following the peer review of the initial risk assessments carried out by the competent authorities of the rapporteur Member State, Sweden, and co‐rapporteur Member State, Italy, for the pesticide active substance bifenazate are reported. The context of the peer review was that required by Commission Implementing Regulation ( EU ) No 844/2012. The conclusions were reached on the basis of the evaluation of the representative uses of bifenazate as an acaricide on strawberry, fruiting vegetables (tomatoes, peppers, aubergines, cucumbers, courgettes, melons, watermelons), flowering and ornamental plants and nursery ornamentals and updated following the request to peer review the exposure and risk assessments for bifenazate. The reliable end points, appropriate for use in regulatory risk assessment, are presented. Missing information identified as being required by the regulatory framework is listed. Concerns are identified.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here